Equity, Access and Utilization of COVID-19 Vaccine in Ebonyi State, Nigeria

Abstract More than a year after vaccine development, COVID-19 vaccine equity remains elusive in the global south. While much is known about vaccine inequity globally, little is known about the in-country situation in Nigeria, and other developing countries, especially after millions of vaccine donat...
Ausführliche Beschreibung

Abstract More than a year after vaccine development, COVID-19 vaccine equity remains elusive in the global south. While much is known about vaccine inequity globally, little is known about the in-country situation in Nigeria, and other developing countries, especially after millions of vaccine donations were received from developed countries and international health organizations. This study investigated the equity in the COVID-19 vaccine rollout, the accessibility to the vaccine, the utilization of vaccination services and the social determinants of health informing the uptake of the COVID-19 vaccine in Ebonyi State, Nigeria. An exploratory research design was adopted for this study using a multistage sampling technique to select 338 sample populations. The survey was administered in-person and online (using ArcGIS Survey123). Six In-Depth Interviews (IDI) and three Key Informant Interviews (KII) were conducted between February and March 2022. The qualitative data were analysed using content and thematic analysis, while descriptive statistics and logistic regression were used in analysing the quantitative data. The findings of this study show that there is vaccine inequity in Ebonyi state across geographical (urban-rural) locations and for those with a disability and those with underlying health conditions. Access to vaccines was at a moderate level, with a significant population of the state not receiving the vaccine. The social determinants of health informing the uptake of the COVID-19 vaccine were knowledge of peers/family members who had taken the vaccine (OR = 2.608, B = 0.959, S.E. = 0.242, p = 0.000), perceived vaccine effectiveness (OR = 1.433, B = 0.36, S.E. = 0.08, p = 0.000), cultural practices (OR = 0.369, B = − 0.998, S.E. = 0.492, p = 0.042) and place of residence (OR = 0.514, B = − 0.665, S.E. = 0.291, p = 0.022). This study concludes that there is vaccine inequity across all levels, with a rising expiration of donated vaccines amidst poor uptake. It is therefore recommended that Nigeria invests in vaccine manufacturing capacity and/or timely partnerships and treaties for vaccine availability, a holistic and integrated approach to vaccination campaigns with mobile vaccination teams deployed to the rural and hard-to-reach areas. Also, more coordinated grassroot vaccine education and awareness campaign could be implemented to increase vaccine uptake levels. Ausführliche Beschreibung

Autor*in:	Busari, Dauda A. [verfasserIn] Nwokporo, Ephraim I.

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2023

Schlagwörter:	Coronavirus Vaccine Equity Pandemic Vaccination

Anmerkung:

© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Übergeordnetes Werk:	Enthalten in: Journal of geovisualization and spatial analysis - [Cham] : Springer International Publishing, 2017, 7(2023), 2 vom: 10. Aug.
Übergeordnetes Werk:	volume:7 ; year:2023 ; number:2 ; day:10 ; month:08

Links:	Volltext

DOI / URN:	10.1007/s41651-023-00154-0

Katalog-ID:	SPR052704696